K0-8 ES11571/ES/NIEHS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2002	1
2003	2
2004	2
2005	3
2006	1
2007	3
2008	2
2024	0

1

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Camp RL, Dolled-Filhart M, Rimm DL. Camp RL, et al. Clin Cancer Res. 2004 Nov 1;10(21):7252-9. doi: 10.1158/1078-0432.CCR-04-0713. Clin Cancer Res. 2004. PMID: 15534099

2

HSP90 as a marker of progression in melanoma.

McCarthy MM, Pick E, Kluger Y, Gould-Rothberg B, Lazova R, Camp RL, Rimm DL, Kluger HM. McCarthy MM, et al. Ann Oncol. 2008 Mar;19(3):590-4. doi: 10.1093/annonc/mdm545. Epub 2007 Nov 23. Ann Oncol. 2008. PMID: 18037622 Free article.

3

Classification of breast cancer using genetic algorithms and tissue microarrays.

Dolled-Filhart M, Rydén L, Cregger M, Jirström K, Harigopal M, Camp RL, Rimm DL. Dolled-Filhart M, et al. Clin Cancer Res. 2006 Nov 1;12(21):6459-68. doi: 10.1158/1078-0432.CCR-06-1383. Clin Cancer Res. 2006. PMID: 17085660

4

Long-term preservation of antigenicity on tissue microarrays.

DiVito KA, Charette LA, Rimm DL, Camp RL. DiVito KA, et al. Lab Invest. 2004 Aug;84(8):1071-8. doi: 10.1038/labinvest.3700131. Lab Invest. 2004. PMID: 15195116 Free article.

5

Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer.

Nadler Y, Camp RL, Schwartz C, Rimm DL, Kluger HM, Kluger Y. Nadler Y, et al. Clin Cancer Res. 2008 Jul 15;14(14):4455-62. doi: 10.1158/1078-0432.CCR-07-5268. Clin Cancer Res. 2008. PMID: 18628459 Free PMC article.

6

Automated subcellular localization and quantification of protein expression in tissue microarrays.

Camp RL, Chung GG, Rimm DL. Camp RL, et al. Nat Med. 2002 Nov;8(11):1323-7. doi: 10.1038/nm791. Epub 2002 Oct 21. Nat Med. 2002. PMID: 12389040

7

Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.

McCarthy MM, Sznol M, DiVito KA, Camp RL, Rimm DL, Kluger HM. McCarthy MM, et al. Clin Cancer Res. 2005 Jul 15;11(14):5188-94. doi: 10.1158/1078-0432.CCR-05-0158. Clin Cancer Res. 2005. PMID: 16033835

8

Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.

Camp RL, Dolled-Filhart M, King BL, Rimm DL. Camp RL, et al. Cancer Res. 2003 Apr 1;63(7):1445-8. Cancer Res. 2003. PMID: 12670887

9

High HSP90 expression is associated with decreased survival in breast cancer.

Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL, Kluger HM. Pick E, et al. Cancer Res. 2007 Apr 1;67(7):2932-7. doi: 10.1158/0008-5472.CAN-06-4511. Cancer Res. 2007. PMID: 17409397

10

Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.

Kluger HM, Chelouche Lev D, Kluger Y, McCarthy MM, Kiriakova G, Camp RL, Rimm DL, Price JE. Kluger HM, et al. Cancer Res. 2005 Jul 1;65(13):5578-87. doi: 10.1158/0008-5472.CAN-05-0108. Cancer Res. 2005. PMID: 15994930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year